Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: A retrospective review

Annals of Surgery

Volumn 259, Issue 2, 2014, Pages 360-368

  Tamura, Koji ^a   Ohtsuka, Takao ^a   Ideno, Noboru ^a   Aso, Teppei ^a   Shindo, Koji ^b   Aishima, Shinichi ^b   Ohuchida, Kenoki ^a   Takahata, Shunichi ^a   Ushijima, Yasuhiro ^c   Ito, Tetsuhide ^a   Oda, Yoshinao ^b   Mizumoto, Kazuhiro ^a   Tanaka, Masao ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Anatomic Pathology ^*  (Japan)

^c Clinical Radiology   (Japan)

Author keywords

clonality; IPMN; main duct type; pancreatic ductal adenocarcinoma; recurrence

Indexed keywords

K RAS PROTEIN;

ADULT; AGED; CANCER SURVIVAL; DAILY LIFE ACTIVITY; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; GENE MUTATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; LIVER METASTASIS; LUNG METASTASIS; MAIN DUCT INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MOLECULAR BIOLOGY; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS RESECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; TUMOR RECURRENCE; VERY ELDERLY;

EID: 84892941095     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3182a690ff     Document Type: Review

References (39)

1. Yamaguchi K, Ohuchida J, Ohtsuka T, et al. Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology. 2002;2:484-490.
2. Ingkakul T, Sadakari Y, Ienaga J, et al. Predictors of the presence of concomitant invasive ductal carcinoma in intraductal papillary mucinous neoplasm of the pancreas. Ann Surg. 2010;251:70-75.
3. Tanno S, Nakano Y, Koizumi K, et al. Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms. Pancreas. 2010;39:36-40.
4. Tanno S, Nakano Y, Sugiyama Y, et al. Incidence of synchronous and metachronous pancreatic carcinoma in 168 patients with branch duct intraductal papillary mucinous neoplasms. Pancreatology. 2010;10:173-178.
5. Yamaguchi K, Kanemitsu S, Hatori T, et al. Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN. Pancreas. 2011;40:571-580.
6. Maguchi H, Tanno S, Mizuno N, et al.Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: a multicenter study in Japan. Pancreas. 2011;40:364-370.
7. Uehara H, Nakaizumi A, Ishikawa O, et al. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Gut. 2008;57:1561-1565.
8. Adsay V, Kloppel G, Fukushima N, et al. Intraductal papillary-mucinous neoplasms of the pancreas. In: Bosman FT, Carneiro F, Hruban RH, et al., eds. World Health Organization Classification of Tumors, Pathology and Genetics of Tumors of the Digestive System. Lyon, France: IARC Press; 2010:304-313.
9. Tanaka M, Chari ST, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms andmucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17-32.
10. Tanaka M, Ferńandez-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12:183-197.
11. Salvia R, Ferńandez-del Castillo C, Bassi C, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg. 2004;239:678-685; discussion 685-687.
12. Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg. 2004;239:788-797; discussion 797-799.
13. Schmidt CM, White PB, Waters JA, et al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology. Ann Surg. 2007;246:644-651; discussion 651-654.
14. Rodriguez JR, Salvia R, Crippa S, et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology. 2007;133:72-79.
15. Schnelldorfer T, Sarr MG, Nagorney DM, et al. Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas. Arch Surg. 2008;143:639-646; discussion 646.
16. Okada K, Imaizumi T, Hirabayashi K, et al. The distance of tumor spread in the main pancreatic duct of an intraductal papillary-mucinous neoplasm: where to resect and how to predict it. J Hepatobiliary Pancreat Sci. 2010;17:516-522.
17. Couvelard A, Sauvanet A, Kianmanesh R, et al. Frozen sectioning of the pancreatic cut surface during resection of intraductal papillary mucinous neoplasms of the pancreas is useful and reliable: a prospective evaluation. Ann Surg. 2005;242:778-780; discussion 774-778.
18. White R, D'Angelica M, Katabi N, et al. Fate of the remnant pancreas after resection of noninvasive intraductal papillary mucinous neoplasm. J Am Coll Surg. 2007;204:987-993.
19. Fujii T, Kato K, Kodera Y, et al. Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas. Surgery. 2010;148:285-290.
20. Passot G, Lebeau R, Hervieu V, et al. Recurrences after surgical resection of intraductal papillary mucinous neoplasm of the pancreas: a single-center study of recurrence predictive factors. Pancreas. 2012;41:137-141.
21. Park J, Lee KT, Jang TH, et al. Risk factors associated with the postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2011;40:46-51.
22. SadakariY, Ienaga J,KobayashiK, et al. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules. Pancreas. 2010;39:232-236.
23. Sadakari Y, Ohuchida K, Nakata K, et al. Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type. Surgery. 2010;147:812-817.
24. Furukawa T, Kl̈oppel G, Adsay V, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447:794-799.
25. Basturk O, Khayyata S, Klimstra DS, et al. Preferential expression of MUC6 in oncocytic and pancreatobiliary types of intraductal papillary neoplasms highlights a pyloropancreatic pathway, distinct from the intestinal pathway, in pancreatic carcinogenesis. Am J Surg Pathol. 2010;34:364-370.
26. Ohtsuka T, Kono H, Tanabe R, et al. Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas. Am J Surg. 2012;204:44-48.
27. Wada K. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas. J Hepatobiliary Pancreat Surg. 2002;9:76-85.
28. Tsutsumi K, Sato N, Cui L, et al. Expression of claudin-4 (CLDN4) mRNA in intraductal papillary mucinous neoplasms of the pancreas. Mod Pathol. 2011;24:533-541.
29. Hong SM, Omura N, Vincent A, et al. Genome-wide CpG island profiling of intraductal papillary mucinous neoplasms of the pancreas. Clin Cancer Res. 2012;18:700-712.
30. Fritz S, Ferńandez-del Castillo C, Mino-Kenudson M, et al. Global genomic analysis of intraductal papillary mucinous neoplasms of the pancreas reveals significant molecular differences compared to ductal adenocarcinoma. Ann Surg. 2009;249:440-447.
31. Morimatsu K, Aishima S, Kayashima T, et al. Liver-intestine cadherin expression is associated with intestinal differentiation and carcinogenesis in intraductal papillary mucinous neoplasm. Pathobiology. 2012;79:107-114.
32. Izawa T,Obara T, Tanno S, et al. Clonality and field cancerization in intraductal papillary-mucinous tumors of the pancreas. Cancer. 2001;92:1807-1817.
33. Matthaei H, Norris AL, Tsiatis AC, et al. Clinicopathological characteristics andmolecular analyses ofmultifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2012;255:326-333.
34. Takuma K, Kamisawa T, Anjiki H, et al. Predictors of malignancy and natural history ofmain-duct intraductal papillary mucinous neoplasms of the pancreas. Pancreas. 2011;40:371-375.
35. Chari ST,YadavD, Smyrk TC, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology. 2002;123:1500-1507.
36. Hruban RH, Pitman MB, Klimstra DS. Tumors of the pancreas. In: Silverberg SG, Sobin LH, eds. Atlas of Tumor Pathology, AFIP Fourth Series, Fascicle 6. Washington, DC: American Registry of Pathology; 2007:75-110.
37. Ideno N, Ohtsuka T, Kono H, et al. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype. Ann Surg. 2013;258:141-151. doi:10.1097/SLA. 0b013e31828cd008.
38. Shi C, Hruban RH. Intraductal papillary mucinous neoplasm. Hum Pathol. 2012;43:1-16.
39. Eguchi H, Ishikawa O, Ohigashi H, et al. Role of intraoperative cytology combined with histology in detecting continuous and skip type intraductal cancer existence for intraductal papillary mucinous carcinoma of the pancreas. Cancer. 2006;107:2567-2575.